The Bloomsbury SET

Connecting capability to combat the threat from infectious disease and antimicrobial resistance



(Credit: Poppy Berdoy-Webster)

Lead higher education institution (HEI): The Royal Veterinary College
Higher education (HE) partners: London School of Economics and Political Science, London School of Hygiene and Tropical Medicine, SOAS University of London
CCF follow on funding award: £1,900,000

With emerging disease at the forefront of news headlines as never before, The Bloomsbury SET is developing new solutions to combat infectious disease and antimicrobial resistance. Through our Impact Connector programme, we will work with businesses to deliver new products (vaccines, diagnostic, therapeutics) that will benefit humans and animals.

Our Impact Connector programme will provide hands-on early-stage commercialisation support for the best new ideas originating from the partner institutions (RVC, LSHTM, LSTM, SOAS). Three overlapping elements of this programme will intersect to support new partnerships with companies, alongside skills training and product development. At the heart of this will be new connections to SMEs, large corporates and not-for-profit organisations that are partners in the Infection Innovation Consortium (iiCON) led by LSTM.

The Bloomsbury SET will focus on delivering support that enables the best technologies to move closer to market. To facilitate this, we will organise activities that introduce our academics to potential company partners. Thereafter, we will offer small grants to nurture these new collaborations. At the same time, a skills development programme will enhance institutional capacity for supporting commercialisation, leading to the creation of new knowledge ecosystems that link universities to industry partners and investors.